Chronic Lymphocytic Leukemia (CLL)

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax, Obinutuzumab)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • La Jolla, California
  • +41 more
Aug 10, 2022

Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)

Completed
  • Cutaneous T-cell Lymphoma (CTCL)
  • +4 more
  • Duarte, California
  • +18 more
Nov 19, 2020

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Idelalisib, Rituximab)

Terminated
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • La Jolla, California
  • +5 more
Oct 19, 2018

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Rituximab, Bendamustine, MEDI-551)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Birmingham, Alabama
  • +53 more
Apr 20, 2017

Chronic Lymphocytic Leukemia (CLL) Trial in La Jolla (Lenalidomide)

Withdrawn
  • Chronic Lymphocytic Leukemia (CLL)
  • La Jolla, California
    UC San Diego Moores Cancer Center
Apr 26, 2017

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in La Jolla, Columbus, Houston (plerixafor)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • La Jolla, California
  • +2 more
Mar 19, 2015

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Idelalisib, Rituximab)

Approved for marketing
  • Chronic Lymphocytic Leukemia (CLL)
  • La Jolla, California
  • +7 more
Oct 27, 2014